{"name":"Olatec Therapeutics LLC","slug":"olatec-therapeutics-llc","ticker":"","exchange":"","domain":"olatecllc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPNEx3eVdsSzFHVi1MSUxRenZ3TnlNbHBoSVhmVFBEYnJ3V3FIX1d5TlFFNnRqSnJWZTUxc1A1V3hyQnFIYUxfcXRxMHQ1b2x4bHpNWVRGTjNwci1SQ2FLZlVpQUowdHptTkVIQnpqdTNVWk95ck45aUdfRlBYdUo1d1ozQWxEajB5RGxoTWxnNkl5Y0VGZlBYYXMzeERSR1JVZ1B3dkVOREk2TXVNWWxMTFc4RW9iWkNwVWVIYWVrY0VCX2htU3NreHFGS3NvVFRBTk52TnZQTFFYVTlyYW1kaHRteWIyQTl1ZEpMc24yRkstUktTdUg5YzVXdFlVeldVMXFMY1NOZ1o?oc=5","date":"2025-09-16","type":"trial","source":"GlobeNewswire","summary":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight - GlobeNewswire","headline":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPbnpLNGxqM1dUX3VWbkJEaWZ1dzY2SWhEUEY3am5VSkNGS1U1czl6S1JKbklnOW9CbzdOZzloQnZLSTFBMnY1TzVIN1AtNFJ3SmhXSUcxRFowTXRDenpkZFlKRmt2cEhRc2QzcFRPMU54dG40bmZoWVF4SUVrNlNhWHNpVnA0LVRrak84MjBpUmRCUk0?oc=5","date":"2025-03-20","type":"regulatory","source":"openPR.com","summary":"Parkinson's Disease Pipeline 2025: FDA Updates, Therapy - openPR.com","headline":"Parkinson's Disease Pipeline 2025: FDA Updates, Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNR3JCQnhRWFJKakk0Ykwxd25Za2xkR2lvY1ZPbGNUR29BaDZiaHZ5TWRZbmxUUm9RaXNPWFNjaFduVUw5NHBZRmZWQ01KYnUwNlVlRzg3UFVZcWJ4eFpzNHk1VGZLNDd4OWwzUllQRkIyZFNsVzB5UDBNd3Q3OGFMQllCR2NDczdtaXhETmhhM0swQ2oxT1NRRnlvdkRQbzRGLWFJX3BqTXRXcHQya3ctdFJEYlc0YlAwdFo0bW1TMFNTQUhSb01scmI2SFYwN3RISDhRUU9yazBLWklLMU9nbEJINGdaa3QtdTh3d0dYdHVnY3R1b2FEZDFWcGk2YkdqX25yOVVNUC1xOVRVWDVKcl80NGgwc0ZwZW9MLUJLYjFmWkl6T1NOT1hXQ1h4eVlNNTVLVU9pWDB4bFBLVUdiSEMzT0wyZ0ZVMERyTmdYanlXWGhwbGc?oc=5","date":"2024-11-13","type":"trial","source":"GlobeNewswire","summary":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire","headline":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxObmtXb2gzT05DQVdvU2tpVmw2RVE5S2tWWXpnay1WakQwU0tBaFo4Q3Q2d0dIVDRaYjhKNTJmTjlGYXVCOUZReGhjZWlKUHB0Q3R1WnA2WUxqbTFkWjdpZkdaUGdybExZc1FRWUdHakRxektlTS1URnp1UUp6Z1dzWG9ZTEppWEs5QkotWGNIcnFMai1ZYTVsOWpXM1JHYUc4bTlXZ242U01jWDNXUnBrQ1AzRGNQMkNJVWdsYXVxcXJFclFzcFZJOHplcEJDU29OaFI4TXFIZmFMVVhHYjRpV1dfN01CTUNkb0ViQmwxcTY0Y1phNHBJUzltU015UU1acFBhTTRBZ2I4Nmc?oc=5","date":"2023-02-23","type":"pipeline","source":"businesswire.com","summary":"Olatec Therapeutics Announces the Final Closing, Led by Sanders Morris Harris, on Its $40 Million Series A Financing Round - businesswire.com","headline":"Olatec Therapeutics Announces the Final Closing, Led by Sanders Morris Harris, on Its $40 Million Series A Financing Rou","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZTZyMExicXNQaUpfWFpCV3NxZDhpeHNsQ2dhenNEb0ZPWXVMQnlsQlhTbjV5YlJnUFBnS1ppQzIxOG5jdE4td2dKQkJHeVpsUHk5bUc5OFhBYkRYb3o0SXg0YVk5QU5vMThOaXlzQkxYSlFKNU1GRTRmbkZTWFBVQ3cxelNrVDBEYlF2SVp1cDBQSVlvRXdwWHNlblpwdkI3c3VYSFRtdWJYTXlUZ1lYQzZMODlMTVNObU9NbzQ1TGlRQQ?oc=5","date":"2022-08-16","type":"pipeline","source":"businesswire.com","summary":"Craig T. Basson, MD, PhD Joins Olatec Therapeutics’ Board of Directors - businesswire.com","headline":"Craig T. Basson, MD, PhD Joins Olatec Therapeutics’ Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOaGsySnFpN0JUV1NPMkVvblUtT0l2MzgwZjRLVkdYSEE4SG9EWGE2QUh1VEJha2FjampOaWY2VzRMWndCcm9obVdkbGhhLTFYR2VYYkpkVkxEQ3RYWDVfM2VMd1Q1QmRwQ3VhUHR5SUxHZEtBMjRaN05GcjNBVEh6Zks2M3NQLU4xcXFV?oc=5","date":"2022-03-15","type":"pipeline","source":"BioSpace","summary":"Mustafa Noor, MD, FACP, Joins Olatec as Chief Medical Officer - BioSpace","headline":"Mustafa Noor, MD, FACP, Joins Olatec as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}